Opto Circuits (India) Ltd's wholly-owned subsidiary EuroCor GmBH has received CE (Communite European) mark approval for marketing its new polymer-free paclitaxel-eluting coronary stent system, called Taxcor-I. | |
| This product, which is used in coronary angioplasty (percutaneous transluminal coronary angioplasty -- PTCA), is a second-generation innovation of EuroCor's present DES (drug-eluting stent) product "" Taxcor. |
| |
| Stents are used for successfully re-opening of narrowed coronary arteries, for full blood flow restoration, to avoid a bypass surgery. |
| |
| EuroCor GmBH is a German manufacturer of cardiovascular devices, in particular coronary stents. OCI acquired EuroCor in December 2005, extending OCI's product mix to invasive medical devices. |
| |
| Explaining the unique technology of the system, Vinod Ramnani, chairman & managing director, OCI, said, "Polymeric drug carriers, coated on the stents, have been known to cause blood clots, also leading to late thrombotic complications. Eurocor is the first manufacturer of a drug-eluting coronary stent system which uses a new, polymer-free drug attachment technology. Taxcor I is thus, a path-breaking technology in the field of DES products. It considerably enhances patient safety and completely eliminates any polymer-related late adverse effects unlike many other DES offerings from global giants." |
| |
|
| |
